Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Jun-Xiang Li"'
Autor:
Peng Zhou, Yan Bao, De-Hua Chang, Jun-Xiang Li, Tian-Zhi An, Ya-Ping Shen, Wen-Wu Cai, Lu Wen, Yu-Dong Xiao
Publikováno v:
Insights into Imaging, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Objective To compare therapeutic outcomes of predicted proliferative and nonproliferative hepatocellular carcinoma (HCC) after microwave ablation (MWA) using a previously developed imaging-based predictive model, the SMARS score. Methods Thi
Externí odkaz:
https://doaj.org/article/026a198f9f4b422dbcef35f85f0ddb8a
Autor:
Shuai Zhang, Zhi‐Mei Cheng, Jia‐LI Yu, Kai Lu, Sheng‐Jie Xu, Yuan Lu, Ting Liu, Bai‐Juan Xia, Zhi Huang, Xu‐Ya Zhao, Wei He, Jun‐Xiang Li, Wei Cao, Yu Huang, Ling Wang, Zhu Zeng, Xun Zou, Rong Liu, Yu‐Sui Zhang, Xiao‐Ping Wu, Tian‐Peng Jiang, Shi Zhou
Publikováno v:
Cancer Medicine, Vol 10, Iss 19, Pp 6795-6806 (2021)
Abstract The incidence and mortality of hepatocellular carcinoma (HCC) are gradually increasing during the past years. Recently, some studies have reported that malic enzyme (ME) plays an important role in cancer development, while the involvement of
Externí odkaz:
https://doaj.org/article/638a5e3032414ee1847aeaf1dd3c4c62
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundBoth the Barcelona Clinic Liver Cancer (BCLC) staging and the Hong Kong Liver Cancer (HKLC) staging have their own definitions of ideal patients for liver resection (IPLR) in hepatocellular carcinoma (HCC). This study aimed to compare the p
Externí odkaz:
https://doaj.org/article/7ae9b3d6e9864cbca180eb76fb010c00
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundHepatocellular carcinoma (HCC) is a highly invasive disease with a high mortality rate. Our previous study found that Chenodeoxycholic acid (CDCA) as an endogenous metabolite can enhance the anti-tumor effect. Sorafenib has limited overall
Externí odkaz:
https://doaj.org/article/40918c602ffc450a98694782857967be
Publikováno v:
Stem Cells International, Vol 2022 (2022)
Pulmonary fibrosis (PF) is a severe chronic lung disease with little effective treatment options other than lung transplantation. Adipose-derived mesenchymal stem cells (ADSCs) have been shown to exert therapeutic effects on PF, but the underlying me
Externí odkaz:
https://doaj.org/article/aa65c8193e0d45e991be6dba58a00b73
Publikováno v:
Journal of International Medical Research, Vol 49 (2021)
Objective To investigative whether the odds tumor enhancement ratio (OTER) on cross-sectional imaging is a prognostic factor for hepatocellular carcinoma after transarterial chemoembolization (TACE). Methods This study involved 126 patients who under
Externí odkaz:
https://doaj.org/article/9e7207538f2746039881f8a97ea5d805
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Objectives: To develop and validate a predictive model for early refractoriness of transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).Methods: In this multicenter retrospective study, a total of 204 consecutive pat
Externí odkaz:
https://doaj.org/article/c7eb398bf2484c91a26ea419733192f9
Autor:
Yao, Tong, Jun-Xiang, Li, De-Hua, Chang, Li-Zhou, Wang, Wen-Wu, Cai, Yan, Bao, Ran, Cai, Yu-Dong, Xiao
Publikováno v:
Annals of Surgical Oncology. 30:2007-2020
Several scoring systems are currently used to predict prognosis of hepatocellular carcinoma (HCC), but none of them integrates liver function, systemic inflammation, and tumor characteristics in a unified model. The current study aimed to develop and
Publikováno v:
Journal of Hepatocellular Carcinoma
Hui-Zhou Li,1 Jie Tan,1 Tian Tang,2 Tian-Zhi An,3 Jun-Xiang Li,4 Yu-Dong Xiao1 1Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Peopleâs Republic of China; 2Department of Interventional Radiolo
Publikováno v:
Journal of Cancer
Purpose: To develop and validate a random forest (RF) based predictive model of early refractoriness to transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma (HCC). Methods: A total of 227 patients with unresec